midodrine has been researched along with Gastroesophageal Reflux in 1 studies
Midodrine: An ethanolamine derivative that is an adrenergic alpha-1 agonist. It is used as a vasoconstrictor agent in the treatment of HYPOTENSION.
midodrine : An aromatic ether that is 1,4-dimethoxybenzene which is substituted at position 2 by a 2-(glycylamino)-1-hydroxyethyl group. A direct-acting sympathomimetic with selective alpha-adrenergic agonist activity, it is used (generally as its hydrochloride salt) as a peripheral vasoconstrictor in the treatment of certain hypotensive states. The main active moiety is its major metabolite, deglymidodrine.
Gastroesophageal Reflux: Retrograde flow of gastric juice (GASTRIC ACID) and/or duodenal contents (BILE ACIDS; PANCREATIC JUICE) into the distal ESOPHAGUS, commonly due to incompetence of the LOWER ESOPHAGEAL SPHINCTER.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gastroesophageal reflux disease (GERD) is a common disease with various clinical presentations." | 2.94 | A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial. ( Anbardar, MH; Bagheri Lankarani, K; Ejtehadi, F; Moini, M; Naini, MA; Nejati, M; Niknam, R; Peymani, P; Sivandzadeh, GR; Taghavi, AR; Zare, M, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagheri Lankarani, K | 1 |
| Sivandzadeh, GR | 1 |
| Zare, M | 1 |
| Nejati, M | 1 |
| Niknam, R | 1 |
| Taghavi, AR | 1 |
| Ejtehadi, F | 1 |
| Naini, MA | 1 |
| Moini, M | 1 |
| Anbardar, MH | 1 |
| Peymani, P | 1 |
1 trial available for midodrine and Gastroesophageal Reflux
| Article | Year |
|---|---|
A preliminary report on the use of Midodrine in treating refractory gastroesophageal disease: Randomized Double-Blind Controlled Trial.
Topics: Adrenergic alpha-1 Receptor Agonists; Adult; Double-Blind Method; Drug Therapy, Combination; Female; | 2020 |